News

Low-dose CT could up early lung cancer detection - at a price


 

He cautioned, however, that the study provides a forecast of cost but does not reflect real-world expenditures.

"This is a model; this is not actual data," he cautioned.

The study was supported by Genentech. Dr. Roth and Dr. Yu reported having no financial disclosures.

Pages

Recommended Reading

AUDIO: Challenges, rewards face creators of pediatric oncofertility clinics
MDedge Internal Medicine
VIDEO: HPV testing predicted to displace most Pap smears
MDedge Internal Medicine
Vitamin D deficiency predicts aggressive prostate cancer
MDedge Internal Medicine
Panel recommends against low-dose CT for lung cancer in Medicare patients
MDedge Internal Medicine
CDC: Policy changes could prevent 100,000 deaths a year
MDedge Internal Medicine
Expanded cytoreduction criteria improved survival of carcinoid liver metastases
MDedge Internal Medicine
Topical tazarotene did not improve response to imiquimod 5% in lentigo maligna
MDedge Internal Medicine
EndoRings-assisted colonoscopy hikes polyp, adenoma detection
MDedge Internal Medicine
Polyp, adenoma detection rises with Endocuff device
MDedge Internal Medicine
Delaying ADT for PSA-only prostate cancer relapse appears safe
MDedge Internal Medicine